Fischer-Tenhagen Carola, Bohm Detlev, Finnah Anke, Arlt Sebastian, Schlesinger Samira, Borchardt Stefan, Sutter Franziska, Tippenhauer Christie M, Heuwieser Wolfgang, Venjakob Peter L
Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, Königsweg 65, 14163 Berlin, Germany.
Center for Protection of Experimental Animals, German Federal Institute for Risk Assessment (BfR), Alt Marienfelde 17-21, 12277 Berlin, Germany.
Animals (Basel). 2023 Aug 8;13(16):2558. doi: 10.3390/ani13162558.
Dry cow treatment with an intramammary antibiotic is recommended to reduce the risk of mastitis at the beginning of the next lactation. The dry period may be shortened unintentionally, affecting antibiotic residue depletion and the time when residues reach concentrations below the maximum residue limit (MRL). The objective of this study was to evaluate residue depletion in milk after dry cow treatment with cloxacillin, considering dry periods of 14 (G14d), 21 (G21d), and 28 d (G28d). Overall, fifteen cows with 60 udder quarters were included in the study. For each cow, three of the udder quarters were treated with 1000 mg cloxacillin benzathine (2:1) on d 252, d 259, and d 266 of gestation; one quarter was left untreated. Milk samples were drawn until 20 DIM and milk composition, somatic cell count and cloxacillin residues were analyzed. The HPLC-MS/MS revealed different excretion kinetics for the compounds cloxacillin and cloxacillin benzathine (1:1). All cows showed a cloxacillin and cloxacillin benzathine (1:1) concentration below the MRL of 30 µg/kg after 5 d. In the udder quarters of G21d and G28d, the cloxacillin concentration was already below the MRL at first milking after calving. The cloxacillin benzathine (1:1) concentration in the milk of G28d, G21d, and G14d fell below 30 µg/kg on the 5th, 3rd, and 5th DIM, respectively. Shortening the dry period affects residue depletion after dry cow treatment with cloxacillin. The risk of exceeding the MRL, however, seems low, even with dry periods shorter than 14 d.
建议使用乳房内抗生素进行干奶期治疗,以降低下一泌乳期初患乳腺炎的风险。干奶期可能会意外缩短,影响抗生素残留的清除以及残留量降至最大残留限量(MRL)以下的时间。本研究的目的是评估用氯唑西林进行干奶期治疗后牛奶中的残留清除情况,考虑14天(G14d)、21天(G21d)和28天(G28d)的干奶期。总体而言,本研究纳入了15头奶牛的60个乳房。对每头奶牛,在妊娠第252天、第259天和第266天,用1000 mg苄星氯唑西林(2:1)对三个乳房进行治疗;一个乳房不进行治疗。采集牛奶样本直至产后20天,并分析牛奶成分、体细胞计数和氯唑西林残留。高效液相色谱-串联质谱法(HPLC-MS/MS)显示氯唑西林和苄星氯唑西林(1:1)的排泄动力学不同。所有奶牛在5天后氯唑西林和苄星氯唑西林(1:1)的浓度均低于30 μg/kg的MRL。在G21d和G28d的乳房中,产犊后首次挤奶时氯唑西林浓度已低于MRL。G28d、G21d和G14d牛奶中苄星氯唑西林(1:1)的浓度分别在产后第5天、第3天和第5天降至30 μg/kg以下。缩短干奶期会影响用氯唑西林进行干奶期治疗后的残留清除。然而,即使干奶期短于14天,超过MRL的风险似乎也很低。